Literature DB >> 11348769

Evaluation of a blocking ELISA for the detection of bovine viral diarrhoea virus (BVDV) antibodies in serum and milk.

F Beaudeau1, C Belloc, H Seegers, S Assié, E Sellal, A Joly.   

Abstract

The performance characteristics of a blocking ELISA test applied to serum and individual milk for the detection of antibodies to bovine viral diarrhoea virus (BVDV) were assessed using 1189 matched milk/serum samples collected from cows of 42 dairy herds located in Brittany (west of France). This test was based on a monoclonal antibody directed against non-structural protein NS2-3 of pestiviruses. All tests were performed blind. For each type of sample, negative/positive cut-off values were determined using receiver operating characteristic (ROC) analysis. Sensitivity and specificity were estimated using the virus neutralisation test as a reference. For sera, the ROC analysis provided a negative/positive inhibition percentage cut-off value of 50% giving a sensitivity and a specificity of 96.9 and 97.8%. For individual milk samples, the cut-off was fixed at 30%, leading to a sensitivity and a specificity of 96.9 and 97.3%. Using this test, a good overall agreement was found between results obtained on matched milk/serum samples (Kappa value=0.95). The present results indicate that this blocking ELISA test is reliable enough for use in a mass screening and control scheme on BVDV.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11348769     DOI: 10.1016/s0378-1135(01)00322-4

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  7 in total

1.  Opportunities for enhanced surveillance of foot-and-mouth disease in endemic settings using milk samples.

Authors:  Bryony Armson; Jemma Wadsworth; Tito Kibona; Deogratius Mshanga; Veronica L Fowler; Nick J Knowles; Valérie Mioulet; Richard Reeve; Donald P King; Katarzyna Bachanek-Bankowska; Tiziana Lembo
Journal:  Transbound Emerg Dis       Date:  2019-02-27       Impact factor: 5.005

2.  Simple Indirect Enzyme-Linked Immunosorbent Assay to Detect Antibodies Against Bovine Viral Diarrhea Virus, Based on Prokaryotically Expressed Recombinant MBP-NS3 Protein.

Authors:  Pezhman Mahmoodi; Masoud Reza Seyfi Abad Shapouri; Masoud Ghorbanpour; Mohammad Rahim Haji Hajikolaei; Mohsen Lotfi; Mahdi Pourmahdi Boroujeni; Maryam Daghari
Journal:  Jundishapur J Microbiol       Date:  2015-01-14       Impact factor: 0.747

3.  Modeling the potential risk factors of bovine viral diarrhea prevalence in Egypt using univariable and multivariable logistic regression analyses.

Authors:  Abdelfattah M Selim; Mahmoud M Elhaig; Sherif A Moawed; Ehab El-Nahas
Journal:  Vet World       Date:  2018-03-02

4.  Production of monoclonal antibody against recombinant NS3 protein of bovine viral diarrhea virus (NADL strain).

Authors:  Masood Reza Seyfi Abad Shapouri; Maryam Ekhtelat; Masood Ghorbanpoor Najaf Abadi; Mohsen Lotfi; Mohamad Rashno
Journal:  Vet Res Forum       Date:  2016-09-15       Impact factor: 1.054

5.  Detection of foot-and-mouth disease virus in milk samples by real-time reverse transcription polymerase chain reaction: Optimisation and evaluation of a high-throughput screening method with potential for disease surveillance.

Authors:  Bryony Armson; Valerie Mioulet; Claudia Doel; Mikidache Madi; Satya Parida; Karissa A Lemire; Diane J Holder; Amaresh Das; Michael T McIntosh; Donald P King
Journal:  Vet Microbiol       Date:  2018-07-29       Impact factor: 3.293

6.  Suitability of individual and bulk milk samples to investigate the humoral immune response to lumpy skin disease vaccination by ELISA.

Authors:  Milovan Milovanović; Vesna Milićević; Sonja Radojičić; Miroslav Valčić; Bernd Hoffmann; Klaas Dietze
Journal:  Virol J       Date:  2020-03-05       Impact factor: 4.099

7.  Estimation of the within-herd transmission rates of bovine viral diarrhoea virus in extensively grazed beef cattle herds.

Authors:  Jun-Hee Han; Jenny F Weston; Cord Heuer; M Carolyn Gates
Journal:  Vet Res       Date:  2019-11-29       Impact factor: 3.683

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.